We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Miners pull UK markets lower, but Smith & Nephew rises

Fri, 30th May 2014 11:34

- Mining stocks lower on iron ore, China concerns- Fenner issues profit warning- M&A continues to boost Smith & NephewtechMARK 2,820.23 +0.39%FTSE 100 6,860.62 -0.16%FTSE 250 16,039.31 +0.53%Weakness in the mining sector dragged the UK stock market from a two-week high on Friday, despite M&A speculation boosting the share prices of Smith & Nephew and Salamander Energy.Mining stocks were trading firmly in the red as iron ore prices were headed for their sixth consecutive monthly decline, the longest losing streak on record. Meanwhile, concerns about a slowdown in China were also having an impact on stocks, as well as a profit warning from polymer products group Fenner, which makes conveyor belts for the mining industry."[Chinese] government figures indicated manufacturing growth was weakening, contradicting recent signs of improvement in the economy and providing an excuse for some selling in raw materials," said Chris Beauchamp, Market Analyst at IG.The FTSE 100 was down 0.2% at 6,861 by midday after hitting 6,871.29 on Thursday, its highest close since May 14th when it reached a new 14-year high of 6,878.49.Investors were also focusing on a batch of mixed economic data from across the globe, including an improvement in consumer confidence in the UK, weak industrial production figures and stronger-than-expected inflation in Japan, and an unexpected dip in retail sales in Germany.Miners weigh on markets, Fenner plummetsRising iron ore supplies from Australia and Brazil have prompted a 9% fall in prices this month, with the value of the commodity having now fallen every month since December. This is the longest string of monthly losses since data from The Steel Index Ltd began in November 2008, according to Bloomberg. Diversified miners Anglo American, BHP Billiton and Rio Tinto were among the worst performers on the FTSE 100, with concerns over China also dampening sentiment.In another hit to sentiment in the mining industry, Fenner issued a profit warning, causing shares to sink sharply. The group said annual profits would be 10-15% below market expectations on the back of weakness in the US coal industry, prompting analysts at Numis Securities to downgrade the stock from 'add' to 'hold'.Meanwhile, solid fuel supplier and logistics group Hargreaves Services also fell after saying results from its Production Division will be below expectations this year due to "challenging trading conditions" in coke markets and delays.Medical device maker Smith & Nephew was on the rise as bid speculation continued to drive the stock higher. While US peer Stryker was forced to publicly deny reports that it was working on a bid for the company, its boss yesterday confirmed in an interview that the company had in fact been in the early stages of considering a transaction but was not ready to make an offer. UBS this morning added the stock to its 'M&A Watch List'.GlaxoSmithKline was fluctuating between gains and losses on rumours that it has approached a number of private equity firms to gauge the interest for a range of its older drugs as it attempts to refresh its portfolio. AIM-listed oil explorer Petroceltic was trading lower after giving investors a trio of "disappointing" updates from its international drilling programme. Meanwhile, sector peer Salamander Energy surged on reports that Cia Espanola de Petroleos SAU is looking to buy to company for €700m.DIY retailer Kingfisher was continuing to fall after an underwhelming first-quarter statement yesterday as Barclays Capital cut the shares to 'equal weight' and trimmed its target price.FTSE 100 - RisersSmith & Nephew (SN.) 1,055.00p +2.53%Coca-Cola HBC AG (CDI) (CCH) 1,390.00p +1.83%Admiral Group (ADM) 1,454.00p +1.82%Hammerson (HMSO) 601.00p +1.18%Whitbread (WTB) 4,182.00p +1.06%Persimmon (PSN) 1,340.00p +1.06%Sports Direct International (SPD) 800.00p +0.88%Land Securities Group (LAND) 1,071.00p +0.85%Sage Group (SGE) 415.10p +0.80%St James's Place (STJ) 786.00p +0.77%FTSE 100 - FallersRio Tinto (RIO) 3,104.50p -2.63%Anglo American (AAL) 1,505.50p -2.56%Fresnillo (FRES) 814.00p -2.52%BHP Billiton (BLT) 1,904.00p -1.88%Morrison (Wm) Supermarkets (MRW) 199.10p -1.53%Antofagasta (ANTO) 795.50p -1.12%Royal Mail (RMG) 512.50p -1.06%G4S (GFS) 250.30p -1.03%Kingfisher (KGF) 393.10p -0.98%Barratt Developments (BDEV) 356.50p -0.94%FTSE 250 - RisersOphir Energy (OPHR) 266.50p +4.02%Micro Focus International (MCRO) 843.00p +3.56%CSR (CSR) 597.50p +3.55%Euromoney Institutional Investor (ERM) 1,178.00p +3.51%Ocado Group (OCDO) 385.20p +3.41%Supergroup (SGP) 1,145.00p +3.25%Xaar (XAR) 847.00p +3.17%Afren (AFR) 154.10p +3.15%Rank Group (RNK) 160.80p +3.08%Perform Group (PER) 272.50p +2.83%FTSE 250 - FallersFenner (FENR) 349.30p -10.37%Paragon Group Of Companies (PAG) 376.80p -3.09%Evraz (EVR) 107.00p -2.01%Drax Group (DRX) 627.00p -1.49%Vedanta Resources (VED) 1,112.00p -1.33%Smith (DS) (SMDS) 318.90p -1.33%Tate & Lyle (TATE) 693.50p -1.14%Playtech (PTEC) 665.00p -1.12%Ferrexpo (FXPO) 137.50p -1.08%TalkTalk Telecom Group (TALK) 318.50p -1.06%BC
More News
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.